ANNAPOLIS, Md., Aug. 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (AMEX:PIP) a biodefense company developing and commercializing medical...
ANNAPOLIS, Md., Aug. 7 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (AMEX:HAQ), a biodefense company developing and commercializing medical...
Healthcare Acquisition Corp. (AMEX:HAQ), a publicly-traded special purpose acquisition company, and PharmAthene, Inc., a...
Healthcare Acquisition Corp. (AMEX:HAQ), a publicly-traded special purpose acquisition company, announced that it has convened...
Please replace the release with the following corrected version due to multiple revisions. The corrected release reads:...
Healthcare Acquisition Corp. (AMEX:HAQ; HAQ.W), announced that a Proxy Statement Supplement was filed with the Securities and...
ANNAPOLIS, Md. and PRINCETON, N.J., July 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc., a biodefense company developing and commercializing...
Healthcare Acquisition Corp. (AMEX:HAQ), a publicly-traded special purpose acquisition company, announced today that it has...
DES MOINES, Iowa, July 19 /PRNewswire-FirstCall/ -- Healthcare Acquisition Corp. (AMEX:HAQ), a publicly-traded special purpose acquisition...
In Vitro Assays Show rBChE Suppresses Amyloid Plaque Formation ANNAPOLIS, Md., April 3 /PRNewswire/ -- PharmAthene, Inc., a leading biodefense...
Pilot Study Demonstrates 50% Survival in Valortim-Treated Animals PRINCETON, N.J., and ANNAPOLIS, Md., March 30 /PRNewswire-FirstCall/...
Transaction Provides PharmAthene With Up to $70 Million in Cash ANNAPOLIS, Md., Jan. 22 /PRNewswire/ -- Privately-owned PharmAthene, Inc., a...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.